Literature DB >> 10478800

H-ras-transformed NRK-52E renal epithelial cells have altered growth, morphology, and cytoskeletal structure that correlates with renal cell carcinoma in vivo.

C J Best1, L R Tanzer, P C Phelps, R L Merriman, G G Boder, B F Trump, K A Elliget.   

Abstract

We studied the effect of the ras oncogene on the growth kinetics, morphology, cytoskeletal structure, and tumorigenicity of the widely used NRK-52E rat kidney epithelial cell line and two H-ras oncogene-transformed cell lines, H/1.2-NRK-52E (H/1.2) and H/6.1-NRK-52E (H/6.1). Population doubling times of NRK-52E, H/1.2, and H/6.1 cells were 28, 26, and 24 h, respectively, with the transformed cells reaching higher saturation densities than the parent cells. NRK-52E cells had typical epithelial morphology with growth in colonies. H/1.2 and H/6.1 cell colonies were more closely packed, highly condensed, and had increased plasma membrane ruffling compared to parent cell colonies. NRK-52E cells showed microfilament, microtubule, and intermediate filament networks typical of epithelial cells, while H/1.2 and H/6.1 cells showed altered cytoskeleton architecture, with decreased stress fibers and increased microtubule and intermediate filament staining at the microtubule organizing center. H/1.2 and H/6.1 cells proliferated in an in vitro soft agar transformation assay, indicating anchorage-independence, and rapidly formed tumors in vivo with characteristics of renal cell carcinoma, including mixed populations of sarcomatoid, granular, and clear cells. H/6.1 cells consistently showed more extensive alterations of growth kinetics, morphology, and cytoskeleton than H/1.2 cells, and formed tumors of a more aggressive phenotype. These data suggest that analysis of renal cell characteristics in vitro may have potential in predicting tumor behavior in vivo, and significantly contribute to the utility of these cell lines as in vitro models for examining renal epithelial cell biology and the role of the ras proto-oncogene in signal transduction involving the cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10478800     DOI: 10.1007/s11626-999-0028-2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  57 in total

1.  The small GTP-binding protein rac regulates growth factor-induced membrane ruffling.

Authors:  A J Ridley; H F Paterson; C L Johnston; D Diekmann; A Hall
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

2.  Introduction of a Ha-ras oncogene into rat liver epithelial cells and parenchymal hepatocytes confers resistance to the growth inhibitory effects of TGF-beta.

Authors:  K A Houck; G K Michalopoulos; S C Strom
Journal:  Oncogene       Date:  1989-01       Impact factor: 9.867

3.  Dose effects of transfected c-Ha-rasVal 12 oncogene in transformed cell clones.

Authors:  L Sistonen; J Keski-Oja; I Ulmanen; E Hölttä; B J Wikgren; K Alitalo
Journal:  Exp Cell Res       Date:  1987-02       Impact factor: 3.905

4.  Modulation of epidermal growth factor receptor binding and action by N-acetyl-TGF alpha (34-43) methyl ester.

Authors:  M Andries; D Tilemans; C Denef
Journal:  Peptides       Date:  1994       Impact factor: 3.750

Review 5.  Pathways of Ras function: connections to the actin cytoskeleton.

Authors:  G C Prendergast; J B Gibbs
Journal:  Adv Cancer Res       Date:  1993       Impact factor: 6.242

6.  Inhibition of invasion of epithelial cells by Tiam1-Rac signaling.

Authors:  P L Hordijk; J P ten Klooster; R A van der Kammen; F Michiels; L C Oomen; J G Collard
Journal:  Science       Date:  1997-11-21       Impact factor: 47.728

7.  Differential sensitivity of normal and H-ras oncogene-transformed rat kidney epithelial cells to okadaic acid-induced apoptosis.

Authors:  M A Davis; S H Chang; B F Trump
Journal:  Toxicol Appl Pharmacol       Date:  1996-11       Impact factor: 4.219

8.  Purification and characterization of cytokine-induced neutrophil chemoattractant produced by epithelioid cell line of normal rat kidney (NRK-52E cell).

Authors:  K Watanabe; S Kinoshita; H Nakagawa
Journal:  Biochem Biophys Res Commun       Date:  1989-06-30       Impact factor: 3.575

9.  Transforming growth factor-alpha expression in human renal cell carcinoma: TGF-alpha expression in renal cell carcinoma.

Authors:  M K Hise; S C Jacobs; J C Papadimitriou; C I Drachenberg
Journal:  Urology       Date:  1996-01       Impact factor: 2.649

10.  Involvement of pRB family in TGF beta-dependent epithelial cell hypertrophy.

Authors:  H A Franch; J W Shay; R J Alpern; P A Preisig
Journal:  J Cell Biol       Date:  1995-04       Impact factor: 10.539

View more
  9 in total

1.  Studies on the mechanisms and kinetics of apoptosis induced by microinjection of cytochrome c in rat kidney tubule epithelial cells (NRK-52E).

Authors:  S H Chang; P C Phelps; I K Berezesky; M L Ebersberger; B F Trump
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

2.  Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia.

Authors:  Charuhas V Thakar; Kamyar Zahedi; Monica P Revelo; Zhaohui Wang; Charles E Burnham; Sharon Barone; Shannon Bevans; Alex B Lentsch; Hamid Rabb; Manoocher Soleimani
Journal:  J Clin Invest       Date:  2005-11-17       Impact factor: 14.808

3.  Increased immunogenicity is an integral part of the heat shock response following renal ischemia.

Authors:  Bettina Bidmon; Klaus Kratochwill; Krisztina Rusai; Lilian Kuster; Rebecca Herzog; Oliver Eickelberg; Christoph Aufricht
Journal:  Cell Stress Chaperones       Date:  2011-12-17       Impact factor: 3.667

4.  Synthesis and evaluation of antitumor activity of novel N-acyllavendamycin analogues and quinoline-5,8-diones.

Authors:  Mohammad Behforouz; Wen Cai; Farahnaz Mohammadi; Mark G Stocksdale; Zhengxiang Gu; Mohammad Ahmadian; Darric E Baty; Michele R Etling; Charmaine H Al-Anzi; Tyson M Swiftney; Lee R Tanzer; Ronald L Merriman; Nancy C Behforouz
Journal:  Bioorg Med Chem       Date:  2006-10-10       Impact factor: 3.641

5.  Calcineurin inhibitors activate the proto-oncogene Ras and promote protumorigenic signals in renal cancer cells.

Authors:  Dipak Datta; Alan G Contreras; Aninda Basu; Olivier Dormond; Evelyn Flynn; David M Briscoe; Soumitro Pal
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

6.  Perfluorooctanesulfonate Mediates Renal Tubular Cell Apoptosis through PPARgamma Inactivation.

Authors:  Li-Li Wen; Chien-Yu Lin; Hsiu-Chu Chou; Chih-Cheng Chang; Hau-Yin Lo; Shu-Hui Juan
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

7.  Isolation of ORCTL3 in a novel genetic screen for tumor-specific apoptosis inducers.

Authors:  S Irshad; A-L Mahul-Mellier; N Kassouf; A Lemarie; S Grimm
Journal:  Cell Death Differ       Date:  2009-03-13       Impact factor: 15.828

8.  L-carnitine protects against carboplatin-mediated renal injury: AMPK- and PPARα-dependent inactivation of NFAT3.

Authors:  Yuh-Mou Sue; Hsiu-Chu Chou; Chih-Cheng Chang; Nian-Jie Yang; Ying Chou; Shu-Hui Juan
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

9.  Epithelial-Fibroblast Crosstalk Protects against Acidosis-Induced Inflammatory and Fibrotic Alterations.

Authors:  Marie-Christin Schulz; Linda Voß; Gerald Schwerdt; Michael Gekle
Journal:  Biomedicines       Date:  2022-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.